Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection

SARS-CoV-2, a member of the coronavirus family, is the causative agent of the COVID-19 pandemic. Currently, there is still an urgent need in developing an efficient therapeutic intervention. In this study, we aimed at evaluating the therapeutic effect of a single intranasal treatment of the TLR3/MDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamir, Hadas, Melamed, Sharon, Erez, Noam, Politi, Boaz, Yahalom-Ronen, Yfat, Achdout, Hagit, Lazar, Shlomi, Gutman, Hila, Avraham, Roy, Weiss, Shay, Paran, Nir, Israely, Tomer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878863/
https://www.ncbi.nlm.nih.gov/pubmed/35215785
http://dx.doi.org/10.3390/v14020189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878863/
https://www.ncbi.nlm.nih.gov/pubmed/35215785
http://dx.doi.org/10.3390/v14020189

Ejemplares similares